TEL : 0091-217 -2310824 : 0091-217 -2451500 FAX : 0091-217 -2451521 E-MAIL : info@balajiamines.com WEBSITE : http://www.balajiamines.com |St November, 20.19 To, The General Manager-Department of Corporate The Manager-Listing Department, Services, National Stock Exchange of India Limited, ``Exchange Plaza'', 5th Floor, BSE Limited Phiroze Jeejebhoy Towers, Plot No. C/1, G Block, Dalal Street, Mumbai -400 001. Bandra-Kurla Complex, Bandra(East), Mumbai -400 051 Scrip Code: 530999 Scrip Code: BALAMINES Dear Sir, Sub: Investor Presentation Pursuant to the Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 we are enclosing herewith the Investor Presentation on the Un-audited Financial Results of the Company for the Second quarter and half year ended 30th September, 2019. The Investor Presentation is also being uploaded on the website of the Company at the URL ±±±p_://www.bala.1.iamines.com/investor~relations Please take same on the record. Thanking You, Yours faithfully, Unit -I : Gal No.197, Vill-Tamalwadi, Tal-Tuljapur. Dist. Osmanabad-413 623. (INDIA) .Tel. : 0091-2471-265013,14,15 . e-mail : factoryofflce@balajiamines.in unit -Ill : Plot No. E-7 & 8, Chincholi M.I.D.C„ Tal. Mohol, Dist. Solapur -413 255. . Tel. : 2357050, 51. e-mail : unit3works@balajiamines.in
Balaji Amines Limited Balaji Amines Limited Investor Presentation - November 2019
Disclaimer This presentation and the accompanying slides (the “Presentation”), which have been prepared by Balaji Amines Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities, and shall not form the basis or be relied on in connection with any contract or binding commitment whatsoever. No offering of securities of the Company will be made except by means of a statutory offering document containing detailed information about the Company. This Presentation has been prepared by the Company based on information and data which the Company considers reliable, but the Company makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this Presentation. This Presentation may not be all inclusive and may not contain all of the information that you may consider material. Any liability in respect of the contents of, or any omission from, this Presentation is expressly excluded. This presentation contains certain forward looking statements concerning the Company’s future business prospects and business profitability, which are subject to a number of risks and uncertainties and the actual results could materially differ from those in such forward looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding fluctuations in earnings, our ability to manage growth, competition (both domestic and international), economic growth in India and abroad, ability to attract and retain highly skilled professionals, time and cost over runs on contracts, our ability to manage our international operations, government policies and actions regulations, interest and other fiscal costs generally prevailing in the economy. The Company does not undertake to make any announcement in case any of these forward looking statements become materially incorrect in future or update any forward looking statements made from time to time by or on behalf of the Company. 2
Q2FY20: Performance Highlights Revenue (Rs. Crore) PAT (Rs. Crore) EBITDA (Rs. Crore) 15.1% Margin 19.8% 8.6% 20.7% 16.0% 14.3% 231.4 45.7 34.7 230.4 44.8 216.3 31.0 37.1 20.0 Q2FY19 Q1FY20 Q2FY20 Q2FY19 Q1FY20 Q2FY20 Q2FY19 Q1FY20 Q2FY20 3
H1FY20: Performance Highlights Revenue (Rs. Crore) PAT (Rs. Crore) EBITDA (Rs. Crore) 17.9% 13.6% Margin 21.7% 11.8% 476.2 103.5 64.8 461.8 54.7 82.7 H1FY19 H1FY20 H1FY19 H1FY20 H1FY19 H1FY20 4
Q2FY20 Result Update Total volumes stood at 21,376 MT for Q2FY20 as against 17,426 MT in Q2FY19 • Amines volumes stood at 4,631 MT • Amines Derivatives volumes stood at 9,024 MT • Specialty Chemicals volumes stood at 7,720 MT Q2FY20 EBITDA margins improved viz-a- viz Q1FY20 margins, on account of the company’s ability to pass on volatility in prices of raw material to end consumers, lower raw material prices and improved offtake End-user industry wise, pharmaceuticals contributed about 56% of revenue, followed by agrochemicals at 19%. Other segments like dyes, textiles, animal feed, water treatment chemicals and refinery contributed about 5% each Pharmaceutical sector’s performance is expected to be range -bound in the medium term as structural challenges persist. Till date, there has been no impact on the sales of DMA HCL, due to the US FDA alert and the related developments on ranitidine drug. However, we expect little impact in Q3FY20 Agrochemicals sector was affected by late onset monsoon that led to deferment of crop sowing. This was coupled with high channel inventory. However, with surplus rainfall across the nation enabling improvement in sowing, the agrochemical sector’s performance is likely to stabilise in H2FY20 Started manufacturing of fungible products – Acetonitrile and THF, for which the company has licensed capacity of 18,000 tons 5
Standalone Statement of Profit & Loss Particulars (in Rs. Crore) Q2FY20 Q2FY19 Y-o-Y Q1FY20 Q-o-Q H1FY20 H1FY19 Y-o-Y Revenue from Operations 230.4 216.3 6.5% 231.4 461.8 476.2 -0.4% -3.0% Raw Material 128.1 113.8 141.4 269.5 255.1 Gross Profit 102.3 102.5 -0.3% 90.1 192.3 221.2 13.5% -13.0% Gross Profit Margin 44.4% 47.4% 38.9% 41.6% 46.4% Employee expense 11.5 12.8 10.7 22.2 25.4 Other expenses 45.1 44.9 42.3 87.4 92.3 EBITDA 45.7 44.8 2.0% 37.1 82.7 103.5 23.2% -20.0% EBITDA Margin 19.8% 20.7% 16.0% 17.9% 21.7% 2.9 1.3 2.3 5.2 2.3 Other Income Depreciation 5.8 4.7 5.0 10.8 9.4 EBIT 42.8 41.4 3.3% 34.4 77.2 96.3 24.2% -19.9% 18.6% 19.1% 14.9% 16.7% 20.2% EBIT Margin Finance Cost 3.8 3.0 2.7 6.4 6.2 Exceptional Items 0.0 0.0 0.0 0.0 0.0 39.0 38.4 1.6% 31.8 70.7 90.1 Profit before Tax 22.8% -21.5% PBT Margin 16.9% 17.7% 13.7% 15.3% 19.6% Tax 4.3 7.4 11.8 16.1 25.3 34.7 31.0 12.0% 20.0 54.7 64.8 Profit after Tax 73.9% -15.6% PAT Margin (%) 15.1% 14.3% 8.6% 11.8% 13.6% EPS (in Rs.) 10.71 9.56 6.16 16.87 20.00 6
Standalone Balance Sheet Statement ASSETS (Rs. Crs.) Sep-19 Mar-19 EQUITY AND LIABILITIES (Rs. Crs.) Sep-19 Mar-19 (1) NON-CURRENT ASSETS EQUITY (a) Equity Share capital 6.5 6.5 (a) Property, plant & equipment 369.8 318.4 (b) Other equity 612.2 568.5 (b) Capital work-in-progress 22.0 63.2 Sub Total (C) 618.7 575.0 (c) Intangible Asset - - LIABILITIES (d) Financial assets - - (1) Non-Current Liabilities - - (i) Investments 66.0 66.0 (a) Financial Liabilities - - (ii) Loans 78.2 32.7 (i) Borrowings - - (iii) Other Financial Assets 123.4 119.4 (ii) Trade Payables 2.1 3.0 (e) Deferred Tax Asset - - (iii) Other Financial Liabilities excl. provisions 122.1 116.9 (f) Other Non - current assets 3.2 1.4 (b) Provisions - - Sub Total (A) 662.5 601.1 (c) Deferred Tax Liabilities (Net) 48.7 45.8 (2) CURRENT ASSETS (d) Other Non-Current Liabilities - - (a) Inventories 88.1 142.6 Sub Total (D) 173.0 165.7 (b) Financial Assets - - (2) Current Liabilities - - (i) Investments - - (a) Financial liabilities - - (ii) Trade receivables 161.0 167.2 (i) Borrowings 126.1 94.6 (ii) Trade Payables 25.7 83.6 (iii) Cash and cash equivalents 4.4 14.4 (iv) Bank Balances other than (iiI) above 2.8 6.1 (iii) Other Financial Liabilities excl. provisions 0.0 0.2 (v) Other Financial Assets - - (b) Other current liabilities - - (c) Current tax assets (net) 16.2 53.3 (c) Provisions 12.6 22.1 (d) Other current assets 38.4 12.6 (d) Current Tax Liabilities (Net) 17.4 56 Sub Total (B) 310.9 396.2 Sub Total (E) 181.7 256.6 Total Assets (A+B) 973.4 997.3 Total Equity & Liabilities (C+D+E) 973.4 997.3 7
Standalone Cash Flow Statement Cash Flow Statement for six months ended (in Rs. Crore) H1FY20 H1FY19 Profit before interest and tax 77.2 96.3 Other income considered -5.2 -2.3 Depreciation 10.8 9.4 Operating profit before working capital changes 82.8 103.5 Changes in working capital 35.7 -21.6 Cash generated from operations 118.5 81.9 Income tax paid (net of refund) -51.7 -49.7 Net Cash from Operating Activities 66.7 32.2 Net Cash from Investing Activities -63.0 -7.8 Net Cash from Financing Activities -17.1 -20.8 Net Change in cash and cash equivalents -13.4 3.5 8
About Us
Recommend
More recommend
